David M. Darst Jr.

Chief Operating Officer, Inspirna, Inc.

David M. Darst Jr.

Chief Operating Officer, Inspirna, Inc.

David M. Darst Jr. is the chief operating officer of Inspirna, Inc., a cancer therapeutics company developing first in class drugs. At Inspirna, he co-leads the company’s financial, corporate development and drug development activities.  

Prior to Inspirna, he was an investor at OrbiMed Advisors, the world’s largest private health care dedicated investment firm. There, he invested in leading private and publicly traded biotechnology companies developing therapeutics for life threatening and debilitating disorders.   

Mr. Darst is also a co-founder, former EVP, and director of Potentia Pharmaceuticals, and a former director of its spin-out company Apellis Pharmaceuticals (Nasdaq: APLS). Apellis’ lead complement inhibitor drug is in late-stage clinical trials for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), age-related macular degeneration (AMD) and other immune disorders.  

Mr. Darst has an MBA from Harvard Business School, and a BA, cum laude, from Harvard College.